Ion Channelopathy: The Important Scientific Clue in CFS with Prof. Sonya Marshall-Gradisnik

Professor Sonya Marshall-Gradisnik is Director of the National Centre for Neuroimmunology and Emerging Diseases (NCNED), Griffith University. She is an immunologist and recognized as the world leader in natural killer (NK) cell and ion channel dysfunction research for the identification of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long Haul COVID-19 through her pioneering technique of electrophysiology patch clamp. Her discoveries are contributing directly to the development of a screening/diagnostic test and improved clinical guidelines and effective treatments for ME/CFS, including pharmacotherapeutics and drug repurposing. Professor Marshall-Gradisnik has achieved sustained success as an independent research leader through successful competitive grants, such as NHMRC and ME Research UK, and numerous philanthropic national and international grants of more than $15 million for over ten years. She has published over 115 scientific publications in the field of ME/CFS, graduated over 45 post graduate students and is an advisor to national and international agencies. Dr. Gradisnik is joined with her colleague Kay Schwarz and research fellow, Natalie Eaton-Fitch, PhD.  Need help navigating your mold injury without breaking the bank? Join our education group: exposingmold.org/membership Exposing Mold is a nonprofit! Donate here: https://www.flipcause.com/secure/cause_pdetails/MTY0OTg0Medical Disclaimer:This podcast is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition.Support the showFind us on Linktree, Facebook, Instagram, Twitter, TikTok and Youtube

There are no comments yet.

Please log in to write the first comment.